Lunai Bioworks Inc.
LNAI • Biotechnology
$0.51
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$2.36M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Weak liquidity · 0.11Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Oct 15, 2026, 12:19 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.51
Change0.00%
Shares Out4.62M
Market Cap$2.36M
Enterprise Value$-372.92M
52W Range0.88 - 13.28
Beta0.35
P/E-0.66
P/S45.37
P/B-0.00
P/FCF-0.45
EV/Sales-7,172.72
Price$0.51
Change0.00%
Shares Out4.62M
Market Cap$2.36M
Enterprise Value$-372.92M
52W Range0.88 - 13.28
Beta0.35
P/E-0.66
P/S45.37
P/B-0.00
P/FCF-0.45
EV/Sales-7,172.72
EV/EBITDA117.31
EV/FCF70.50
Earnings Yield-151.02%
FCF Yield-224.23%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq-0.15
Current Ratio0.11
Quick Ratio0.11
Volume69.57K
Avg Volume705.41K
Investment DNA
How strong this company looks for long-term investors
44
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
45/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Weak liquidity · 0.11Weak profitability
Analyst view
No analyst data available now.
🧾
No insider activity
No recent insider transactions available.